TSTickerStarGet alerts
Company alerts/BMGL
BMGL company alerts

BMGL updates worth following

TickerStar monitors official filings, investor releases, earnings, and call updates for BMGL. Subscribe to BMGL alerts to receive concise, source-linked alerts when TickerStar detects a meaningful company update.

Subscribe for BMGL alertsView companies
Official-source feed

Recent BMGL alert previews

TickerStar filters routine noise and surfaces investor-relevant filings, releases, earnings, and call updates.

Debt offeringSEC filing

Basel Medical Group Ltd Files FY2026 Annual Report on Form 20-F

Basel Medical Group Ltd filed its annual report on Form 20-F for the fiscal year ended June 30, 2026, reporting revenue of S$16.4 million (US$12.8 million), a 45.2% increase from S$11.3 million in FY2025. The company completed its acquisition of Bethesda Medical Pte. Ltd. in April 2025 and recognized a full goodwill impairment of S$10.3 million related to the acquisition. Subsequent to year-end, the company completed a registered direct offering raising approximately US$7.98 million in gross proceeds and is defe...

Read source-backed brief
WebcastEarnings call webcast

BMGL Q3 2026: $1.2B ADC Transaction De-Risks Legacy Reserves; Industrial Ventures Rebound Drives 14% Op Income Growth

BMGL's Q3 2026 call was defined by a strategic cleanup of legacy liabilities through a $1.2 billion Adverse Development Cover (ADC) with Enstar, aimed at providing finality to the run-off Global Re division and other exited lines. Management clarified that the $120 million risk premium for this protection will be effectively EPS-neutral in the fourth quarter, as it is offset by the release of existing management margins within the reserves. This move allows the company to pivot focus toward its high-performing I...

Read source-backed brief
Debt offeringSEC filing

Basel Medical Group Ltd prices $7.98M registered direct offering of units

On October 7, 2026, Basel Medical Group Ltd (Nasdaq: BMGL) entered into a placement agency agreement with Cathay Securities, Inc. and a securities purchase agreement with certain purchasers to issue and sell 6,000,000 units at $1.33 per unit in a registered direct offering, for total gross proceeds of US$7.98 million and estimated net proceeds of approximately US$7.28 million. Each unit consists of one ordinary share (or one Pre-Funded Warrant in lieu thereof) and one Common Warrant exercisable at 110% of the un...

Read source-backed brief
Debt offeringSEC filing

Basel Medical Group Ltd closes $7.98 million registered direct offering of units

On October 13, 2026, Basel Medical Group Ltd (Nasdaq: BMGL) furnished a Form 6-K reporting the closing of a registered direct offering of 6,000,000 units at US$1.33 per unit, with gross proceeds of US$7.98 million and estimated net proceeds of approximately US$7.28 million. Each unit consists of one Ordinary Share (or one Pre-Funded Warrant in lieu, none of which were issued) and one Common Warrant exercisable at US$1.463 (110% of the unit price) for five years, with a zero-cash-exercise option. The Company inte...

Read source-backed brief